undefined undefined undefined

Validation of the ATTR-CM score for transthyretin amyloid cardiomiopathy in a mediterranean cohort of patients at risk

Event: ESC Congress 2023

Topic: Diagnostic Methods

Session: Diagnostics - old and new - and their uses in heart failure

Access

Like

Lack of association between celiac disease and idiopathic dilated cardiomyopathy

Event: Heart Failure 2023

Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Session: Comorbidities

Access

Like

External validation and extension of the HCM-AF score for the prediction of atrial fibrillation in hypertrophic cardiomyopathy patients.

Event: Heart Failure 2023

Topic: Hypertrophic Cardiomyopathy

Session: Myocardial disease - hypertrophic cardiomyopathy 1

Access

Like

Validation of a clinical score for transthyretin amyloid cardiomiopathy in a mediterranean cohort of patients at risk

Event: Heart Failure 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure - epidemiology, prognosis, outcome 4

Access

Like

Alcohol abstinence vs. persistent alcohol consumption in alcoholic cardiomyopathy: impact on long-term prognosis

Event: ESC Congress 2022

Topic: Lifestyle Modification

Session: Chronic heart failure - Diet, alcohol, nutrition

Access

Like

Predictors of LV reverse remodelling.

Event: Heart Failure 2022

Topic: Chronic Heart Failure

Session: Recent onset cardiomyopathy: a need for risk stratification

Access

Like

Head-to-head comparison of NT-proBNP and soluble ST2 for long-term prognosis of patients with hypertrophic cardiomyopathy

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Myocardial and pericardial disease e-posters

Access

Like

Clinical and prognostic significance of the inflammatory markers GlycA and GlycB in chronic heart failure of both ischemic and non-ischemic etiologies.

Event: ESC Congress 2021 - The Digital Experience

Topic: Biomarkers

Session: Chronic heart failure e-posters

Access

Like

Association and long-term prognostic value of the inflammatory markers GlycA and GlycB in heart failure from ischemic and non-ischemic etiology.

Event: Heart Failure 2021

Topic: Biomarkers

Session: ePoster session

Access

Like

Comparison of N-terminal pro-brain natriuretic peptide and soluble interleukin-1 receptor-like 1 in predicting prognosis of patients with hypertrophic cardiomyopathy

Event: Heart Failure 2021

Topic: Hypertrophic Cardiomyopathy

Session: ePoster session

Access

Like

undefined undefined undefined

Contributor content

Validation of the ATTR-CM score for transthyretin amyloid cardiomiopathy in a mediterranean cohort of patients at risk

Lack of association between celiac disease and idiopathic dilated cardiomyopathy

External validation and extension of the HCM-AF score for the prediction of atrial fibrillation in hypertrophic cardiomyopathy patients.

Validation of a clinical score for transthyretin amyloid cardiomiopathy in a mediterranean cohort of patients at risk

Alcohol abstinence vs. persistent alcohol consumption in alcoholic cardiomyopathy: impact on long-term prognosis

Predictors of LV reverse remodelling.

Head-to-head comparison of NT-proBNP and soluble ST2 for long-term prognosis of patients with hypertrophic cardiomyopathy

Clinical and prognostic significance of the inflammatory markers GlycA and GlycB in chronic heart failure of both ischemic and non-ischemic etiologies.

Association and long-term prognostic value of the inflammatory markers GlycA and GlycB in heart failure from ischemic and non-ischemic etiology.

Comparison of N-terminal pro-brain natriuretic peptide and soluble interleukin-1 receptor-like 1 in predicting prognosis of patients with hypertrophic cardiomyopathy

ESC 365 is supported by